Why TRT ordering is a cadence and routing problem
Unlike a weight-loss titration that escalates, a TRT program often settles into a stable regimen the patient stays on for months. That makes the ordering question about cadence and routing: can you reorder a steady regimen predictably, route each order to the right 503A partner, and keep per-vial cost stable across cycles. The Rx Spot connects operators to 503A pharmacies that compound testosterone and related hormones through its partner network, but the platform's primary model is a white-label patient storefront where patients order directly. Clinics that batch in-office TRT refills from an ops portal should confirm how that mode works and whether per-vial cost is visible before a session.
This page is about ordering workflow, not clinical TRT management. The therapy regimen is a prescriber decision; the platform's job is to make a stable regimen reorder cleanly, route it to the right compounder, and show per-vial cost before checkout. What you should evaluate is whether the platform supports recurring refills, multi-pharmacy routing, and cost visibility for a long-running program managed from the clinic side — not a patient-facing storefront.